Cyclin dependent kinase 4 (cdk4) activity is controlled by the binding of regulatory subunits and inhibitory factors, as well as tyrosine and serine/threonine phosphorylation. More recently the in¯uence of calcium levels have been demonstrated. Using transient transfections in Jurkat cells, we observed speci®c binding between cdk4 and the calcium and calmodulin activated serine/threonine phosphatase, calcineurin. Furthermore, we demonstrated that the inhibition of the phosphatase activity of calcineurin with FK506 and cyclosporin A resulted in an overall increase in cdk4 kinase activity, suggesting that the phosphatase activity of calcineurin was inhibitory to the kinase activity of cdk4. In contrast, we were not able to observe a similar eect on the kinase activity of either cdk6 or cdk2, indicating that the phosphatase activity of calcineurin was speci®c for cdk4. In addition, using an in vitro phosphatase assay for calcineurin, we observed that the exogenous addition of calcineurin resulted in the dephosphorylation of cdk4, an event that downregulated the kinase activity of cdk4. Calcineurin could, therefore, play an opposing role to the action of the cyclin activating kinase complex, an enzyme that upregulates the kinase activity of cdk4, an important G 0 /G 1 checkpoint element in mammalian cells.
Introduction
Lymphocyte activation involves the interaction of calcineurin with the nuclear factor of activated T cells, NFAT (Klee et al., 1998) . Calcineurin is a calcium activated serine/threonine phosphatase that exists as a heterodimer, formed by the association of a 60 kDa phosphatase catalytic subunit (calcineurin A) and a 19 kDa high anity calcium binding subunit (calcineurin B) . Activation of calcineurin involves the binding of calcium bound-calmodulin (CaM) to the carboxy terminus of calcineurin A, resulting in the displacement of an autoinhibitory domain from the phosphatase catalytic active site. These events then allow calcineurin substrates to gain access to the catalytic site and undergo dephosphorylation.
The activation of calcineurin and subsequent dephosphorylation of its substrate, NFAT, is central to lymphokine activation (Northrop et al., 1994) . Dephosphorylation of NFAT is required for its translocation to the nucleus (in a complex with calcineurin) (Shibasaki et al., 1996) , whereby NFAT forms heterodimers with AP-1 family members when binding to NFAT/AP-1 sites in the interleukin (IL)-2 promoter (Chen et al., 1998) . In addition to regulating the production of IL-2, NFAT family members also regulate numerous other lymphokines including IL-4, IL-3, GM-CSF, and IFN-g (reviewed in Rao et al., 1997) . Inhibition of the phosphatase activity of calcineurin is obtained by the binding of the fungal macrolides, FK506 and cyclosporin A (CsA). Speci®cally, FK506 and CsA bind to endogenous proteins, the immunophilins ± the FK506 binding proteins (FKBPs) and the cyclosporin A binding proteins (the cyclophilins ± CyPs) (Fruman et al., 1994) . FK506, CsA, or the immunophilins by themselves do not inhibit the phosphatase activity of calcineurin. However, as a complex of FK506/FKBP or CsA/CyP, they can inhibit the activity of calcineurin by sterically blocking the access of substrates to the phosphatase catalytic site (Grith et al., 1995) .
Cyclin dependent kinase 4 (cdk4) is a central element controlling cellular proliferation. Its activity is tightly controlled by several mechanisms that include binding of inhibitory proteins (such as the p16 INK4 family members) (Sherr and Roberts, 1995) , association with cyclin subunits, and serine/threonine and tyrosine phosphorylation (Morgan, 1995) . All cyclin dependent kinase family members are regulated by an activating phosphorylation event (mediated by the cyclin activating kinase or CAK) on threonine-172 for cdk4, threonine-176 for cdk6, and threonine-161 for cdc2 and cdk2 (Morgan, 1995) . This active phosphorylation, combined with binding of a cyclin counterpart (cyclin D for cdk4), allows the active form of cdk4 to translocate to the nucleus where it can phosphorylate target proteins and promote cell cycle entry. In the case of cdk4, the main target protein is the p110 protein product of the retinoblastoma (Rb) tumor suppressor gene (Knudsen and Wang, 1996) . In the quiescent state, Rb associates with the transcription factor E2F and represses E2F-dependent gene transcription of important S phase genes. Cyclin D/cdk4-dependent phosphorylation of Rb during late G 0 /G 1 releases E2F, allowing E2F to activate E2F responsive elements on speci®c S phase genes, such as DNA polymerase II, thymidine kinase, and cyclin E (Weinberg, 1995) . When cells are ready to return to the quiescent state, Rb becomes sequentially dephosphorylated by serine/ threonine phosphatase(s) and by the downregulation of cdk activity.
The role played by calcium in the proliferation of eukaryotic cells has been mainly stimulated by eorts to understand how the high anity calcium binding protein, calmodulin, interacts with proteins involved in cell cycle control. We present data that suggest a role for the calcium and calmodulin regulated serine/ threonine phosphatase, calcineurin, in the control of the mammalian G 0 /G 1 checkpoint kinase, cdk4. We observed a physical interaction with cdk4, a decrease in cdk4 kinase activity in the presence of active calcineurin, as well as an enhancement of the activity of cdk4 in the presence of calcineurin inhibiting drugs, FK506 and CsA. Thus, calcineurin may play an important role in the control of cellular proliferation in T lymphocytes by the regulation of cdk4 kinase activity.
Results

Calcineurin physically interacts with cdk4
In order to investigate potential substrates for calcineurin, we prepared whole cell lysates from an asynchronous population of a human leukemic T cell line, Jurkat, and precipitated calcineurin (Cn) binding proteins using a CaM/Cn anity matrix. Immunoblotting with an anti cdk4 antibody, we demonstrated that cdk4 speci®cally associated with the matrix of CaM/ Cn-Sepharose ( Figure 1a , lane 3) and not with a Sepharose matrix or with CaM-Sepharose devoid of exogenously added calcineurin ( Figure 1a , lanes 1 and 2 respectively). Preincubation of CaM/Cn-Sepharose with the complex of FK506/FKBP12 dramatically inhibited the amount of cdk4 bound to CaM/Cn Sepharose ( Figure 1a , lane 4), suggesting a speci®c interaction of calcineurin with cdk4. Furthermore, under similar experimental conditions, neither cdk6 nor cdk2 bound to the CaM/Cn-Sepharose (data not shown), suggesting that calcineurin may have speci®city for cdk4.
To further de®ne the interaction of calcineurin with cdk4, immunoprecipitation studies were performed using Jurkat cells transiently transfected with either: (1) wild type calcineurin A (CnA), (2) a constitutively active form of calcineurin A (containing a deletion of the carboxy terminal autoinhibitory and CaM-binding domains and thus in the open conformation containing calcium-independent catalytic activity) (CnAd), or (3) a phosphatase dead mutant of calcineurin A (CnAd-H151A) (Figure 1b ). CnAdH151A is also missing the carboxy terminal autoinhibitory and CaM-binding domains, but contained a histidine to alanine substitution in a critical residue important for stabilizing the phosphate group and thus lacked catalytic activity (Grith et al., 1995; Shibasaki et al., 1996) . Immunoprecipitation using an anti-cdk4 antibody demonstrated that the interaction between calcineurin and cdk4 preferentially occurred with the form of calcineurin in the open conformation (CnAd and CnAdH151A) (Figure 1b, lanes 3 and 4) , even though all forms of calcineurin A were expressed at comparable levels ( Figure 1b , bottom panel, lanes 2 ± 4). Interestingly, the observation that cdk4 antibodies were able to immunoprecipitate the point mutant of calcineurin A (Figure 1b, lane 4) suggests that, although devoid of catalytic activity, this mutant can still associate with cdk4 and may possibly behave as a trapping mutant for calcineurin substrates (Zhu and McKeon, 1999) .
Calcineurin activity inhibits the kinase activity of cdk4
In order to determine whether calcineurin binding to cdk4 in¯uenced cdk4 kinase activity, we assessed the kinase activity of cdk4 in an in vitro kinase assay using, as a substrate, the carboxy terminal residues of the p110 protein product of Rb ligated to glutathione Stransferase (GST-RbC) (Matsushime et al., 1994) . Lysates were prepared from Jurkat cells transiently transfected with the indicated vectors and cdk4 kinase activity was assessed. The expression of active calcineurin resulted in a reduction of cdk4 kinase activity by 50% ( Figure 2a , lane 3; Figure 2b ), that was reversed by the in vivo addition of the calcineurin Figure 2b ). Cdk4 kinase activity was enhanced by 45% above vector in the presence FK506 or CsA, suggesting that the phosphatase activity of calcineurin could regulate the kinase activity of cdk4, and that FK506 and CsA were present in amounts sucient to inhibit the phosphatase activity of both the transfected and endogenous pools of calcineurin. Both FK506 and CsA inhibited the phosphatase activity of calcineurin by 10-fold under similar experimental conditions ( Figure 2c) ; and the amount of wild type, active calcineurin and cdk4 were equivalent. ) is the quantitation of four separate cdk4 IVK assays using GST-RbC as the substrate. (c) The activity of calcineurin under the conditions of FK506 and CsA treatment was assessed using a peptide from the regulatory subunit of protein kinase A as the substrate (Fruman et al., 1992) . The data is a representation of four separate experiments. (d) Jurkat cells were transiently transfected with the GST-tagged constitutively active calcineurin A (lane 1) and GSTtagged phosphatase dead calcineurin A (lane 2). Cdk4 IVK analysis was carried out as outlined in (a). WCL, whole cell lysate blotted with a rabbit anti-cdk4 antibody neurin may compete with endogenous calcineurin for cdk4 binding and thus prevent the dephosphorylation of cdk4, resulting in a greater proportion of the active kinase.
Calcineurin can directly regulate the phosphorylation level of cdk4
Cdk4 is known to undergo two distinct phosphorylation events ± one that leads to maximal kinase activity (phosphorylation of threonine-172 by CAK) ; and one that leads to the inhibition of its kinase activity (phosphorylation of tyrosine-17 and threonine-19) (Jinno et al., 1999) . An asynchronous population of COS-7 cells was transfected with either vector control (pEBG), wild type, constitutively active and phosphatase dead forms of calcineurin and cdk4 was immunoprecipitated with a phosphospeci®c antibody for phosphorylated threonine-172 (PT101). Overexpression of the constitutively active form of calcineurin resulted in a loss of the ability of PT101 to immunoprecipitate cdk4 ( Figure 3, lane 3) ; however, in the presence of the phosphatase dead form of calcineurin, cdk4 remained phosphorylated and PT101 regained its ability to immunoprecipitate cdk4 ( Figure  3 , lane 4). PT101 was speci®c for phosphorylated cdk4 and we were not able to immunoprecipitate phosphorylated cdk6 under simliar transfection conditions (data not shown).
In order to further assess the direct regulation of cdk4, an asynchronous population of Jurkat cells was treated with FK506 for 16 h, lysed and cdk4 complexes were immunoprecipitated and associated kinase activity was assessed ( Figure 4a ). As observed for transiently transfected Jurkat cells, inhibition of the phosphatase activity of calcineurin by FK506 resulted in the enhancement of the kinase activity of cdk4 ( Figure  4a ; compare lane 2 to lane 1), supporting a role for calcineurin in the downregulation of the kinase activity of cdk4. Furthermore, when the immunoprecipitated active cdk4 complex from an asynchronous population of cells was in vitro dephosphorylated using puri®ed CaM-bound calcineurin, we observed a 70% reduction in the kinase activity of cdk4 towards GST-RbC (Figure 4a, lane 3) . The loss of cdk4 kinase activity towards GST-RbC, as a result of the in vitro addition of calcineurin (Figure 4a, lane 3) , would suggest a role for calcineurin in the regulation of threonine-172 phosphorylation ± a site regulated by CAK. We further tested this hypothesis in an in vitro kinase assay for CAK phosphorylation of cdk4. CAK obtained from an asynchronous population of NIH3T3 cells phosphorylated GST-cdk4 (Figure 4b, lane 1) . However, the addition of exogenous CaM-bound calcineurin to the CAK phosphorylated GST-cdk4 resulted in a 30% reduction of the intensity of phosphorylated GSTcdk4 ( Figure 4b , lane 2) and this reduction was reversed by the addition of EDTA/EGTA, a known inhibitor of calmodulin activation of calcineurin (Figure 4b, lane 3) . Therefore, the loss of calcineurin activity in the presence of EDTA/EGTA resulted in the lack of dephosphorylation of GST-cdk4, and hence a sustained phosphorylation of GST-cdk4 (Figure 4b , lane 3). Thus, calcineurin may act in direct opposition to the action of CAK and regulate residue(s) targeted by CAK.
The phosphatase activity of calcineurin is specific for cdk4
To assess the selectivity of the phosphatase activity of calcineurin for cdk4, we transiently transfected Jurkat cells with calcineurin, immunoprecipitated cdk6 and cdk2 and carried out in vitro kinase assays using GSTRbC as the substrate for cdk6 (Figure 4c ) and histone H1 as the substrate for cdk2 (data not shown). Calcineurin did not change the kinase activity of cdk6 or cdk2, and the inhibition of calcineurin by FK506 did not aect the kinase activity of either cdk6 towards GST-RbC (compare Figure 4c , lanes 3 and 4 with Figure 2a , lanes 3 and 4) or cdk2 towards histone H1 (data not shown). In addition, we looked at the ability of calcineurin to directly dephosphorylate immunoprecipitated cdk6 and cdk2 from an asynchronous population of cells using an in vitro dephosphorylation assay with puri®ed CaM-bound calcineurin (Figure 4d ). We did not observe a reduction in the kinase activity of either cdk2 or cdk6 as was observed for cdk4 (compare Figure 4d , lanes 2 and 3 with Figure  4a , lanes 2 and 3).
Calcineurin preferentially downregulates the kinase activity of cdk4 during mitosis
To determine if calcineurin could modulate cdk4 kinase activity in a cell cycle dependent manner, Jurkat cells were synchronized at four distinct points of the cell cycle using 0.5% fetal calf serum (G 0 /G 1 phase), 5 mg/ml aphidicolin (late G 1 phase), 750 mM hydroxyurea (S phase), or 500 ng/ml nocodozole (M phase). Cell cycle arrest experiments carried out in the presence and absence of FK506 revealed that the kinase activity of cdk4 towards GST-RbC was increased primarily during the nocodazole synchronized phase or M phase of the cell cycle having 40% more activity when the phosphatase activity of calcineurin was inhibited by FK506 (Figure 5a ). The hydroxyurea synchronized phase or S phase kinase activity of cdk4 was also elevated by FK506 treatment and would suggest that cdk4 kinase activity may start to become downregulated by calcineurin during the DNA synthesis phase of the cell cycle and continue into the mitotic phase resulting in further downmodulation of the kinase activity of cdk4. Inhibition of the activity of this phosphatase would result in the continued activation of cdk4 kinase activity ( Figure  5a ). Cdk4 protein levels were comparable in the presence and absence of FK506, as was the level of calcineurin (data not shown) and we were able to observe similar results in NIH3T3 and COS-7 cells (data not shown).
Discussion
Cyclin dependent kinases (cdk) are regulated spatiotemperally as cells cycle through G 0 /G 1 to the mitotic phase. The activation state of these enzymes are dependent on phosphorylation events that possibly control their cellular localization and substrate speci®city. Cyclin activating kinase (CAK) has been shown to activate cdk4, cdk6 and cdk2 (Morgan, 1995) . Cdk4 and cdk6 are important G 0 /G 1 cyclin dependent kinases that use the family of D cyclins to assemble into an active kinase complex, while cdk2 is an important G2/M phase transition cyclin dependent kinase that associates with cyclin E.
Much less is known about the phosphatases that are responsible for the dephosphorylation and subsequent downregulation of the cyclin dependent kinases. In this study, we demonstrated that calcineurin can physically associate with cdk4, possibly dephosphorylate CAK phosphorylated residues and thus downmodulate cdk4 kinase activity. The regulation of cdk4 kinase activity is dependent upon the phosphatase activity of calcineurin, since the phosphatase dead form of calcineurin could not downmodulate the kinase activity of cdk4. In addition, calcineurin demonstrated selectivity towards the G 0 /G 1 kinase, cdk4, as we were not able to observe a similar modulation of cdk2 kinase activity nor of cdk6 kinase activity, a cyclin dependent kinase that is also abundant and active during the exit from G 0 /G 1 . The lack of modulation of cdk6 kinase activity by calcineurin and the lack of cdk6 association with a calcineurin anity matrix would support a direct interaction between calcineurin and cdk4 rather than via the D cyclin family. Furthermore, FK506 inhibition of the activity of calcineurin resulted in the elevation of the kinase activity of cdk4, suggesting that the phosphatase activity of calcineurin was required for the downregulation of the kinase activity of cdk4.
Recently, it was determined that members of the major class of serine/threonine protein phosphatases could play essential roles in the regulation of cyclin dependent kinases that control cellular proliferation. 2) and then subjected to a cdk4 IVK assay. For lane 3, the Protein A-bound cdk4 kinase complex from lane 1 was incubated with 2.5 mg of exogenously added CaM-bound calcineurin for 20 min at 308C; calcineurin was then removed by washing the beads with three washes of 16 kinase buer, followed by a cdk4 IVK assay with GST-RbC as the substrate. (b) A CAK IVK assay ± 2 mg GST-cdk4/Histidine tagged (His)-cyclin D2 was added to 100 ml of a sonicated NIH3T3 lysate (5610 5 cells) as the source of CAK . The reaction was allowed to proceed for 1 h at 258C in CAK lysis buer with 10 mCi g-32 P-ATP added to the reaction mixture. Lane 1 ± CAK phosphorylated GST-cdk4 (65 pmols) immobilized to Glutathione Sepharose beads. For lanes 2 and 3, 2.5 mg (43 pmols) of puri®ed CaM-bound calcineurin was added to Glutathione Sepharose beads containing immobilized GST-cdk4/His-cyclin D2, either without (lane 2) or with (lane 3) 2.5 mM EGTA/1 mM EDTA added in order to inactive the phosphatase activity of calcineurin. The resultant radiolabeled GST-cdk4 was separated by SDS ± PAGE, transferred to PVDF, and autoradiographed for 4 days to visualize radiolabeled proteins. Protein phosphatase (PP) 1 was found to directly regulate the phosphorylation status of the p110 protein product of the retinoblastoma (Rb) tumor suppressor gene in Balb/c 3T3 cells and thus directly regulate the transcriptional activity of E2F. PP2A phosphatase activity resulted in the decrease in cdk4, cdk6, and cdk2 kinase activity by decreasing cyclin D2 and cyclin E protein levels, while increasing the expression levels of p21 CIP and p27 KIP (but not p16) in Balb/c 3T3 cells (Yan and Mumby, 1999) . In the budding yeast, Saccharomyces cerevisiae, both calcineurin (PP2B) (Mizunuma et al., 1998) and PP2C activity (Cheng et al., 1999) were demonstrated to downmodulate the activity of p34
CDC28
, an important G2/M checkpoint cdk in budding yeast. p34
CDC28 becomes activated at the onset of mitosis by the coordinated action of kinases and phosphatases. In cooperation with Mpk1 (a component of the MAP kinase pathway), the activation of calcineurin was shown to downregulate p34 CDC28 by increasing the activity of the inhibitory kinase, Swe1, on a trancriptional and translational level and thus prevent the entrance into mitosis. In contrast, PP2C-like activity was demonstrated to directly regulate the kinase activity of p34 CDC28 in Saccharomyces cerevisiae and cdk2 and cdk6 kinase activity in HeLa cell extracts by directly dephosphorylating the activating phosphorylation event mediated by CAK. In this study, we were not able to observe changes in cdk6 and cdk2 kinase activity, nor changes in the levels of expression of p21 CIP and p27 KIP in either Jurkat or COS-7 cells when the phosphatase activity of calcineurin was inhibited (data not shown). We are proposing that calcineurin may play a role in speci®cally downregulating cdk4 kinase activity during the mitotic phase, possibly opposing the action of CAK. These results illustrate the complex nature of the regulation of cyclin dependent kinases and the important roles played by the various members of the serine/threonine phosphatase family in the cellular control of proliferation.
Materials and methods
Antibodies and immunoprecipitation
The following polyclonal antibodies were used: rabbit anticalcineurin B (Anity Bioreagents, Inc, Golden, CO, USA); rabbit anti-human cdk4 (C-22) and rabbit anti-human cdk6 (C-21) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); PT101, a phosphothreonine-proline (TpP) speci®c antibody (New England BioLabs, Waltham, MA, USA). For cdk4 and cdk6 immunoprecipitations, cells (20610 6 ) were lysed in 880 ml of DIP buer containing 50 mM HEPES pH 7.2, 150 mM NaCl, 10% glycerol, 0.1% Tween-20, 1% Triton X-100, 1 mM DTT, 1 mM sodium¯uoride, 0.5 mM sodium vanadate, 10 mM b-glycerophosphate, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 100 mg/ml PMSF. Lysed cells were spun down at 14 000 r.p.m. for 15 min, protein concentrations were normalized using the Bradford assay, and immunoprecipitations were carried out by adding either 10 mg of rabbit anti-calcineurin B; 0.5 mg rabbit anti-cdk4; 1 mg of rabbit anti-cdk6 to the lysate; 0.5 mg of PT101. Immunoprecipitations were allowed to proceed overnight at 48C, followed by the addition of 30 ml of a 50% slurry of BSA blocked Protein A Sepharose beads. After 2 h the beads were washed extensively with DIP buer, and the proteins bound to the beads were resolved by SDS ± PAGE (Laemmli, 1970) , transferred to polyvinylidene di¯uoride (PVDF), immunoblotted with the indicated antibody, and developed by the enhanced chemiluminescence (ECL) system (Amersham Corp.).
Cells lines and DNA transfections
Jurkat cells were grown in complete medium (RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM L- Figure 5 Cell cycle dependent downregulation of the kinase activity of cdk4 by calcineurin. (A) Asynchronously growing Jurkat cells were allowed to undergo cell cycle synchronization using the indicated drugs for 22 h either with or without FK506 (added at the same time as the addition of the synchronization drugs). After 22 h the cells were harvested and lysed in DIP buer, normalized to total protein content, and then immunoprecipitated with a rabbit anti-cdk4 antibody and a cdk4 IVK assay (using GST-RbC as the substrate) was carried out as outlined in Materials and methods. The IVK assay was repeated three times and the data normalized to the activity present in an asynchronous population of Jurkat cells (100% activity). (b) Flow cytometry (FACS) of synchronized cells using propidium iodide staining of the cells glutamine, penicillin and streptomycin). Transfections were carried out using electroporation with settings of 800 mF, low ohm and a voltage of 250 V. Cells (1610 7 /500 ml) were used with approximately 12 mg of CsCl 2 prepared DNA. Inhibition of calcineurin activity was carried out by the addition of 100 nM FK506 (Calbiochem, La Jolla, CA, USA) or 5 mM cyclosporin A (Sandoz Pharmaceuticals, NJ, USA) 3 h post transfection, followed by the incubation of the cells for 16 h at 378C.
Generation of calcineurin eukaryotic expression vectors
Human calcineurin Aa (CnA) was cloned into the elongation factor 1a-driven vector, pEBG; calcineurin B was cloned into the vector, pEBB (generous gifts of Dr Bruce Mayer, The Children's Hospital and Harvard Medical School, Boston, MA, USA). pEBG encodes for glutathione S-transferase (GST), positioned 5' to the multiple cloning site. pEBB is the parent vector for pEBG and does not contain GST. Therefore, all calcineurin A constructs were GST-tagged at the amino terminus. pET-CnA/B (encoding human calcineurin Aa) was used as the PCR template in the construction of the wild type (CnA) and constitutively active form of calcineurin A (CnAd); and pET-CnAdH151A/B was used in the construction of the phosphatase dead form of calcineurin A (CnAdH151A) (both vectors were generous gifts of Dr Mondragon, Massachusetts Institute of Technology, Boston, MA, USA) (Mondragon et al., 1997) . For pEBG-CnA (wild type): 5' primer was GGTCGGATCCATGTCCGAGCC-CAAGGC and 3' primer was AGCAGCAATATCCAGTG-AGGACCCTGC; pEBG-CnAd (amino acids 1 ± 368): 5' primer was the same one used for the wild type construct and 3' primer was: AAGGAAGTCATCAGAAACG-GATCCCTGC. For the phosphatase dead form of calcineurin: same primers as for pEBG-CnAd. For calcineurin B, pGEX-3X-CnB was used as the PCR template using GGGGATCCCCATGGGAAGTGAGGCGAGT as the 5' primer and GGGGATCCTCACACATCCACCACCAT as the 3' reverse primer.
In vitro interaction experiments
Experiments using CaM-Sepharose beads were carried out as outlined by Wesselborg et al. (1996) . Brie¯y, CaM-Sepharose beads were charged by washing in Tris-buered saline containing 1 mM CaCl 2 . Calcineurin (Cn) (Sigma Chemical CO., St. Louis, MO, USA) was added to a ®nal concentration of 55 nM and lysates were then applied to the CaM/Cn anity matrix and incubated for 1 h at 48C. Inhibition of binding was carried out by preincubation with 4 mM FK506 and 4 mM FKBP12 for 1 h at 48C in 250 ml of lysis buer. Subsequently, lysates were added and incubated for 1 h at 48C. Beads were washed four times with precipitation wash buer and bound proteins resolved by SDS ± PAGE, immunoblotted with an anti-cdk4 antibody, and developed by an enhanced chemiluminescence (ECL) system.
Cdk4 and cdk6 kinase assays
In vitro kinase assays (IVK) were performed for cdk4 and cdk6 as described elsewhere (Matsushime et al., 1994) . Immunoprecipitations were carried out for 1 h at 48C. Protein A Sepharose was added for 1 h, prewashed four times with E-DIP lysis buer (DIP buer with 2.5 mM EGTA/1 mM EDTA). After Protein A Sepharose precipitation, the beads were washed four times with E-DIP buer, followed by two washes with 16 kinase buer (50 mM HEPES, pH 7.2, 10 mM MgCl 2 , 5 mM MnCl 2 , 1 mM DTT). The kinase reaction mixture (25 ml) contained 16 kinase buer, 10 mCi g-32 P-ATP (New England Nuclear, Boston, MA, USA), 250 mM ATP, and 0.65 mg GST-RbC fusion protein as substrate (GST-RbC: amino acids 772 ± 928 of the p110 protein product of Rb) (Boston Biologicals, Inc., Waltham, MA, USA). The mixture was incubated at 378C for 30 min and the reaction was stopped by adding SDS ± PAGE loading buer. The samples were boiled for 10 min and resolved using a 10% SDS ± PAGE. The gel was then dried, autoradiographed and quantitated using a BioRad phosphoimager.
Cell cycle synchronization
Synchronized cells were prepared as previously described (Krek and DeCaprio, 1995) . Brie¯y, Jurkat cells (20610 6 ) were serum starved for 22 h at 378C in medium containing 0.5% fetal bovine serum to achieve G 0 /G 1 arrest; with 5 mg/ ml aphidicolin (Sigma Chemical CO., St. Louis, MO, USA) to arrest cells in late G 1 ; 750 mM hydroxyurea (Sigma Chemical CO., St. Louis, MO, USA) was used for S phase arrest; 500 ng/ml nocodazole (Sigma Chemical CO., St. Louis, MO, USA) was used for M phase arrest. Late G 1 , S and M phase cell cycle synchronizations were performed at 378C in 15 ml of complete RPMI media. After 22 h the cells were lysed in 880 ml of DIP buer and then incubated with the appropriate antibody for IVK assays.
